| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 245 |
| 1 | BOTULINUM TOXIN TYPE A | 70 |
| 2 | DEOXYCHOLIC ACID | 54 |
| 3 | OMEPRAZOLE MAGNESIUM | 33 |
| 4 | OMEPRAZOLE | 32 |
| 5 | OCTREOTIDE ACETATE | 30 |
| 6 | ASPIRIN | 28 |
| 7 | TEMOZOLOMIDE | 28 |
| 8 | ASPIRIN 325 MG | 27 |
| 9 | ASPIRIN 81 MG | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERTACONAZOLE NITRATE | 6 | 0.0370 |
| 1 | DEOXYCHOLIC ACID | 54 | 0.0231 |
| 2 | SORBITOL | 5 | 0.0083 |
| 3 | ESOMEPRAZOLE SODIUM | 19 | 0.0078 |
| 4 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| 5 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 1 | 0.0067 |
| 6 | BOTULINUM TOXIN TYPE A | 70 | 0.0055 |
| 7 | TROLAMINE SALICYLATE | 1 | 0.0052 |
| 8 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 9 | TITANIUM DIOXIDE | 1 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 338 |
| 1 | Neuromuscular Blocker [EPC] | 338 |
| 2 | Cytolytic Agent [EPC] | 54 |
| 3 | Atypical Antipsychotic [EPC] | 52 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 52 |
| 5 | Benzodiazepine [EPC] | 51 |
| 6 | Proton Pump Inhibitor [EPC] | 44 |
| 7 | Corticosteroid [EPC] | 37 |
| 8 | Alkylating Drug [EPC] | 36 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 54 | 0.0231 |
| 1 | Acetylcholine Release Inhibitor [EPC] | 338 | 0.0034 |
| 2 | Oxytocic [EPC] | 5 | 0.0016 |
| 3 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 4 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 7 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 8 | Actinomycin [EPC] | 2 | 0.0009 |
| 9 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |